Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions.

Vaccines (Basel) · 2026 · PMC12944923 · PMID 41746058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The interim data reported in August 2020 showed a highly significant improvement in OS benefit, showing a median OS of 10.5 months in comparison with historic controls that have reported a median OS of 5.3 months (log rank test, p < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.